Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXercise to Prevent AnthraCycline-based Cardio-Toxicity 2.0 (EXACT2) in Individuals With Breast Cancer

NCT03748550 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT03748550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXercise to Prevent AnthraCycline-based Cardio-Toxicity 2.0 (EXACT2) in Individuals With Breast Cancer
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 29, 2019
Completion date
December 31, 2025
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, breast, cardiotoxicity, cardiovascular diseases